A mobile prostate cancer screening program proved feasible for men in underserved neighborhoods and led to a high rate of ...

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

MyCareGorithm was met with high approval from patients, companions, and physicians, with all 3 groups reporting they’d ...

Annual Symposium held in San Francisco, CA between February 13–15, 2025 was host to a prostate cancer poster session. Dr. Ida Sonni presented a study evaluating the diagnostic performance of 18 ...

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

For the third year in a row, Carver Bank, the largest Black-owned financial institution, brought prostate cancer screenings.

New research maps the global burden of male cancers from 1990 to 2040, showing how aging, lifestyle, and healthcare access ...

The 18-gene MyProstateScore 2.0 (MPS2) test using first-catch non-digital rectal examination (DRE) urine is highly se ...

Discover a study that concludes that the reduction in PSA screening has had a widespread impact on men in the US.

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

When prostate cancer metastasizes, spreads outside of the prostate itself, it typically affects the structures in its immediate vicinity. Structures near the prostate likely to be involved include ...

A recent study from researchers at Vanderbilt University and the University of Michigan has demonstrated that a simple at-home urine test can accurately screen for prostate cancer. The findings, ...